INTERNATIONAL PATENT: ACTUATE THERAPEUTICS, INC. FILES APPLICATION FOR "BIOMARKERS FOR USE IN PANCREATIC CANCER TREATMENT"

GENEVA, Oct. 28 -- ACTUATE THERAPEUTICS, INC. (1751 River Run, Suite 400Fort Worth, Texas 76107) filed a patent application (PCT/US2025/024259) for "BIOMARKERS FOR USE IN PANCREATIC CANCER TREATMENT" on Apr 11, 2025. With publication no. WO/2025/221600, the details related to the patent application was published on Oct 23, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): MAZAR, Andrew P. (c/o Actuate Therapeutics, Inc.1751 River Run, Suite 400Fort Worth, Texas 76107), UGOLKOV, Andrey (c/o Actuate Therapeutics, Inc.1751 River Run, Suite 400Fort Worth, Texas 76107)

Abstract: Provided herein ar...